Ocuphire Pharma (OCUP) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free OCUP Stock Alerts $1.73 0.00 (0.00%) (As of 09:30 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ocuphire Pharma Short Interest DataCurrent Short Volume1,220,000 sharesPrevious Short Volume1,580,000 sharesChange Vs. Previous Month-22.78%Dollar Volume Sold Short$1.93 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 30, 2024Outstanding Shares25,924,000 sharesPercentage of Shares Shorted4.71%Today's Trading Volume5,049 sharesAverage Trading Volume213,940 sharesToday's Volume Vs. Average2% Short Selling Ocuphire Pharma ? Sign up to receive the latest short interest report for Ocuphire Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOCUP Short Interest Over TimeOCUP Days to Cover Over TimeOCUP Percentage of Float Shorted Over Time Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. Ocuphire Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,220,000 shares $1.93 million -22.8%N/A5.3 $1.59 4/15/20241,580,000 shares $2.78 million +0.6%N/A7.1 $1.76 3/31/20241,570,000 shares $3.16 million -4.9%N/A7.1 $2.01 3/15/20241,650,000 shares $3.14 million -2.4%N/A7.8 $1.90 2/29/20241,690,000 shares $4.29 million -3.4%N/A7.9 $2.54 2/15/20241,750,000 shares $4.64 million +1.2%N/A8.1 $2.65 Get the Latest News and Ratings for OCUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,730,000 shares $4.53 million +4.2%N/A7.6 $2.62 1/15/20241,660,000 shares $4.98 million +5.1%N/A7.6 $3.00 12/31/20231,580,000 shares $4.76 million -9.7%N/A7.3 $3.01 12/15/20231,750,000 shares $4.60 million -0.6%N/A6.2 $2.63 11/30/20231,760,000 shares $5.37 million +3.5%N/A6.4 $3.05 11/15/20231,700,000 shares $5.36 million -2.3%N/A6.5 $3.15 10/31/20231,740,000 shares $4.96 million -7.5%N/A7.1 $2.85 10/15/20231,880,000 shares $6.28 million +3.9%N/A8.2 $3.34 9/30/20231,810,000 shares $6.06 million +27.5%N/A8.1 $3.35 9/15/20231,420,000 shares $5.69 million -2.7%N/A8.2 $4.01 8/31/20231,460,000 shares $5.83 million -8.2%N/A10.2 $3.99 8/15/20231,590,000 shares $6.66 million -1.2%N/A9.5 $4.19 7/31/20231,610,000 shares $6.97 million -1.2%N/A6.8 $4.33 7/15/20231,630,000 shares $6.75 million +5.2%N/A5.1 $4.14 6/30/20231,550,000 shares $6.73 million +5.4%N/A4.2 $4.34 6/15/20231,470,000 shares $5.87 million -4.6%N/A3.8 $3.99 5/31/20231,540,000 shares $5.94 million -24.5%N/A4.1 $3.86 5/15/20232,040,000 shares $10.24 million +11.5%N/A6 $5.02 4/30/20231,830,000 shares $9.39 million +45.2%N/A6.9 $5.13 4/15/20231,260,000 shares $6.75 million +86.7%N/A5.2 $5.36 3/31/2023675,000 shares $2.53 million -25.5%N/A4.2 $3.75 3/15/2023906,400 shares $3.40 million +0.2%N/A7.2 $3.75 2/28/2023904,800 shares $3.12 million -3.4%N/A7 $3.45 2/15/2023936,500 shares $3.59 million -5.8%N/A6.8 $3.83 1/31/2023994,000 shares $3.45 million -7.1%N/A3.7 $3.47 1/15/20231,070,000 shares $3.94 million +5.9%N/A4.4 $3.68 12/30/20221,010,000 shares $3.57 million -3.8%N/A4.3 $3.53 12/15/20221,050,000 shares $3.10 million -1.9%N/A5 $2.95 11/30/20221,070,000 shares $3.30 million -5.3%N/A5.2 $3.08 11/15/20221,130,000 shares $3.22 million +220.3%N/A5.7 $2.85 10/31/2022352,800 shares $829,080.00 +16.5%N/A2 $2.35 10/15/2022302,800 shares $663,132.00 -25.1%N/A3.9 $2.19 9/30/2022404,300 shares $812,643.00 -12.0%N/A5.3 $2.01 9/15/2022459,400 shares $1.06 million -0.4%N/A5.4 $2.30Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. OCUP Short Interest - Frequently Asked Questions What is Ocuphire Pharma's current short interest? Short interest is the volume of Ocuphire Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,220,000 shares of OCUP short. Learn More on Ocuphire Pharma's current short interest. What is a good short interest ratio for Ocuphire Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUP shares currently have a short interest ratio of 5.0. Learn More on Ocuphire Pharma's short interest ratio. Which institutional investors are shorting Ocuphire Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocuphire Pharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Ocuphire Pharma's short interest increasing or decreasing? Ocuphire Pharma saw a decrease in short interest in April. As of April 30th, there was short interest totaling 1,220,000 shares, a decrease of 22.8% from the previous total of 1,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocuphire Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ocuphire Pharma: HCW Biologics Inc. (0.05%), NextCure, Inc. (0.53%), Gain Therapeutics, Inc. (1.02%), Eyenovia, Inc. (12.11%), CASI Pharmaceuticals, Inc. (0.73%), VYNE Therapeutics Inc. (0.68%), Unicycive Therapeutics, Inc. (2.13%), Aadi Bioscience, Inc. (6.50%), Xilio Therapeutics, Inc. (5.24%), Lexaria Bioscience Corp. (2.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Ocuphire Pharma stock? Short selling OCUP is an investing strategy that aims to generate trading profit from Ocuphire Pharma as its price is falling. OCUP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocuphire Pharma? A short squeeze for Ocuphire Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUP, which in turn drives the price of the stock up even further. How often is Ocuphire Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: HCWB Short Squeeze NXTC Short Squeeze GANX Short Squeeze EYEN Short Squeeze CASI Short Squeeze VYNE Short Squeeze UNCY Short Squeeze AADI Short Squeeze XLO Short Squeeze LEXX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity